202 related articles for article (PubMed ID: 36070444)
1.
Sharma R; Chu E; Dill LK; Shad A; Zamani A; O'Brien TJ; Casillas-Espinosa PM; Shultz SR; Semple BD
J Neurotrauma; 2023 Feb; 40(3-4):365-382. PubMed ID: 36070444
[TBL] [Abstract][Full Text] [Related]
2. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia.
Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J
Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain.
Semple BD; O'Brien TJ; Gimlin K; Wright DK; Kim SE; Casillas-Espinosa PM; Webster KM; Petrou S; Noble-Haeusslein LJ
J Neurosci; 2017 Aug; 37(33):7864-7877. PubMed ID: 28724747
[TBL] [Abstract][Full Text] [Related]
4. Age exacerbates the CCR2/5-mediated neuroinflammatory response to traumatic brain injury.
Morganti JM; Riparip LK; Chou A; Liu S; Gupta N; Rosi S
J Neuroinflammation; 2016 Apr; 13(1):80. PubMed ID: 27090212
[TBL] [Abstract][Full Text] [Related]
5. Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury.
Liu S; Zhang L; Wu Q; Wu Q; Wang T
J Mol Neurosci; 2013 Nov; 51(3):1021-9. PubMed ID: 23934512
[TBL] [Abstract][Full Text] [Related]
6. The Chemokine CCL2 Mediates the Seizure-enhancing Effects of Systemic Inflammation.
Cerri C; Genovesi S; Allegra M; Pistillo F; Püntener U; Guglielmotti A; Perry VH; Bozzi Y; Caleo M
J Neurosci; 2016 Mar; 36(13):3777-88. PubMed ID: 27030762
[TBL] [Abstract][Full Text] [Related]
7. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ
J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963
[TBL] [Abstract][Full Text] [Related]
8. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice.
Semple BD; Bye N; Rancan M; Ziebell JM; Morganti-Kossmann MC
J Cereb Blood Flow Metab; 2010 Apr; 30(4):769-82. PubMed ID: 20029451
[TBL] [Abstract][Full Text] [Related]
9. Chemokine signaling mediated monocyte infiltration affects anxiety-like behavior following blast injury.
Murugan M; Ravula A; Gandhi A; Vegunta G; Mukkamalla S; Mujib W; Chandra N
Brain Behav Immun; 2020 Aug; 88():340-352. PubMed ID: 32240765
[TBL] [Abstract][Full Text] [Related]
10. Pediatric traumatic brain injury and a subsequent transient immune challenge independently influenced chronic outcomes in male mice.
Sharma R; Casillas-Espinosa PM; Dill LK; Rewell SSJ; Hudson MR; O'Brien TJ; Shultz SR; Semple BD
Brain Behav Immun; 2022 Feb; 100():29-47. PubMed ID: 34808288
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 signaling in reactive astrocytes counteracts neuroinflammation and ameliorates neuronal damage after traumatic brain injury.
Gao X; Li W; Syed F; Yuan F; Li P; Yu Q
J Neuroinflammation; 2022 Feb; 19(1):43. PubMed ID: 35135580
[TBL] [Abstract][Full Text] [Related]
12. CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.
Morganti JM; Jopson TD; Liu S; Riparip LK; Guandique CK; Gupta N; Ferguson AR; Rosi S
J Neurosci; 2015 Jan; 35(2):748-60. PubMed ID: 25589768
[TBL] [Abstract][Full Text] [Related]
13. Pre-existing
Baker TL; Uboldi AD; Tonkin CJ; Wright DK; Vo A; Wilson T; Mychasiuk R; McDonald SJ; Semple BD; Sun M; Shultz SR
Front Mol Neurosci; 2022; 15():1079097. PubMed ID: 36683847
[TBL] [Abstract][Full Text] [Related]
14. CCR2 deficiency alters activation of microglia subsets in traumatic brain injury.
Somebang K; Rudolph J; Imhof I; Li L; Niemi EC; Shigenaga J; Tran H; Gill TM; Lo I; Zabel BA; Schmajuk G; Wipke BT; Gyoneva S; Jandreski L; Craft M; Benedetto G; Plowey ED; Charo I; Campbell J; Ye CJ; Panter SS; Nakamura MC; Eckalbar W; Hsieh CL
Cell Rep; 2021 Sep; 36(12):109727. PubMed ID: 34551293
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling.
Cazareth J; Guyon A; Heurteaux C; Chabry J; Petit-Paitel A
J Neuroinflammation; 2014 Jul; 11():132. PubMed ID: 25065370
[TBL] [Abstract][Full Text] [Related]
16. The Role of CCL2/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: From Animal Experiments to Clinical Trials.
Geng H; Chen L; Tang J; Chen Y; Wang L
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408846
[TBL] [Abstract][Full Text] [Related]
17. CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.
Hsieh CL; Niemi EC; Wang SH; Lee CC; Bingham D; Zhang J; Cozen ML; Charo I; Huang EJ; Liu J; Nakamura MC
J Neurotrauma; 2014 Oct; 31(20):1677-88. PubMed ID: 24806994
[TBL] [Abstract][Full Text] [Related]
18. Epileptogenesis after traumatic brain injury in Plaur-deficient mice.
Bolkvadze T; Puhakka N; Pitkänen A
Epilepsy Behav; 2016 Jul; 60():187-196. PubMed ID: 27208924
[TBL] [Abstract][Full Text] [Related]
19. Exploration of novel ligands to target C-C Motif Chemokine Receptor 2 (CCR2) as a promising pharmacological treatment against traumatic brain injury.
Sachdev KR; Lynch KJ; Barreto GE
Biomed Pharmacother; 2022 Jul; 151():113155. PubMed ID: 35598371
[TBL] [Abstract][Full Text] [Related]
20. Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury.
Puntambekar SS; Saber M; Lamb BT; Kokiko-Cochran ON
Brain Behav Immun; 2018 Jul; 71():9-17. PubMed ID: 29601944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
